Cited by 111

The DOI matches its Crossref record.

Insulin-activated Erk-mitogen-activated Protein Kinases Phosphorylate Sterol Regulatory Element-binding Protein-2 at Serine Residues 432 and 455 in Vivo

Kotzka, Jorg, Lehr, Stefan, Roth, Gunther, Avci, Haluk, Knebel, Birgit, Muller-Wieland, Dirk·2004·Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m401198200

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The MEK1/ERK cascade directly phosphorylates SREBP2 at Ser-432 and Ser-455, inhibiting its sumoylation and promoting its transcription activity.

    “Previous studies in HepG2 cells showed that MEK1/ERK cascade directly phosphorylates SREBP2 at Ser-432 and Ser-455, which inhibits its sumoylation and subsequently promotes its transcription activity (Arito et al., 2008; Kotzka et al., 2004; Kotzka et al., 2000).”

    From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Kotzka et al., 2004

    The Results identify Ser-432 and Ser-455 as Erk2 phosphorylation sites and show that activating the Erk pathway with MEK2D increases SREBP-2 transcriptional activity in HepG2 cells. Our copy does not establish that phosphorylation inhibits sumoylation, and the HepG2 experiment uses MEK2D rather than MEK1. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • ERK1/2 signaling has been previously shown to regulate SREBP2 activity in HepG2 cells via direct phosphorylation.

    “ERK1/2 signaling has been previously shown to regulate SREBP2 activity in HepG2 cells via direct phosphorylation (Arito et al., 2008; Kotzka et al., 2004; Kotzka et al., 2000)”

    From GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis (2019) · cites this paper as Kotzka et al., 2004

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 26

  1. Briggs, 1993, J. Biol. Chem., 268, 14490, 10.1016/S0021-9258(19)85265-1 · DOI · Paper page
  2. Wang, 1993, J. Biol. Chem., 268, 14497, 10.1016/S0021-9258(19)85266-3 · DOI · Paper page
  3. Hua, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 11603, 10.1073/pnas.90.24.11603 · DOI · Paper page
  4. Tontonotz, 1993, Mol. Cell. Biol., 13, 4753
  5. Yokoyama, 1993, Cell, 75, 187, 10.1016/S0092-8674(05)80095-9 · DOI
  6. Amemiya-Kudo, 2002, J. Lipid Res., 43, 1220, 10.1194/jlr.M100417-JLR200 · DOI
  7. Brown, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 11041, 10.1073/pnas.96.20.11041 · DOI · Paper page
  8. Kotzka, 1998, Biochem. Biophys. Res. Commun., 249, 375, 10.1006/bbrc.1998.9161 · DOI
  9. Kotzka, 2000, J. Lipid Res., 41, 99, 10.1016/S0022-2275(20)32079-4 · DOI · Paper page
  10. Streicher, 1996, J. Biol. Chem., 271, 7128, 10.1074/jbc.271.12.7128 · DOI · Paper page
  11. Meyer, 1991, Methods Enzymol., 201, 206, 10.1016/0076-6879(91)01019-X · DOI
  12. Kim, 1995, Mol. Cell. Biol., 15, 2582, 10.1128/MCB.15.5.2582 · DOI
  13. Treisman, 1996, Curr. Opin. Cell Biol., 8, 205, 10.1016/S0955-0674(96)80067-6 · DOI · Paper page
  14. Whitmarsh, 2000, Cell Mol. Life Sci., 57, 1172, 10.1007/PL00000757 · DOI
  15. Widmann, 1999, Physiol. Rev., 79, 143, 10.1152/physrev.1999.79.1.143 · DOI
  16. Roth, 2000, J. Biol. Chem., 275, 33302, 10.1074/jbc.M005425200 · DOI
  17. Sato, 1994, J. Biol. Chem., 269, 17267, 10.1016/S0021-9258(17)32550-4 · DOI
  18. Atchley, 1999, J. Mol. Evol., 48, 501, 10.1007/PL00006494 · DOI
  19. Shimano, 1997, J. Clin. Invest., 99, 846, 10.1172/JCI119248 · DOI · Paper page
  20. Oliner, 1996, Genes Dev., 10, 2903, 10.1101/gad.10.22.2903 · DOI
  21. Berberich, 1992, Genes Dev., 6, 166, 10.1101/gad.6.2.166 · DOI
  22. Bousset, 1993, Oncogene, 8, 3211
  23. Koskinen, 1994, Cell Growth & Differ., 8, 313
  24. Wadman, 1994, Oncogene, 9, 3713
  25. Prasad, 1997, J. Biol. Chem., 272, 11457, 10.1074/jbc.272.17.11457 · DOI
  26. Wu, 2002, J. Biol. Chem., 277, 42669, 10.1074/jbc.M205501200 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kotzka, J., Lehr, S., Roth, G., Avci, H., Knebel, B., & Muller-Wieland, D.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-05
Volume
279
Issue
21
Pages
22404-22411
ISSN
0021-9258
Cited by
111
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review